JP2014510081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014510081A5 JP2014510081A5 JP2013558154A JP2013558154A JP2014510081A5 JP 2014510081 A5 JP2014510081 A5 JP 2014510081A5 JP 2013558154 A JP2013558154 A JP 2013558154A JP 2013558154 A JP2013558154 A JP 2013558154A JP 2014510081 A5 JP2014510081 A5 JP 2014510081A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- item
- oral formulation
- seed extract
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 claims description 93
- 238000009472 formulation Methods 0.000 claims description 63
- 239000000203 mixture Substances 0.000 claims description 63
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 50
- 229940087603 grape seed extract Drugs 0.000 claims description 49
- 235000002532 grape seed extract Nutrition 0.000 claims description 49
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 49
- 239000003795 chemical substances by application Substances 0.000 claims description 41
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 29
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 29
- 240000007817 Olea europaea Species 0.000 claims description 29
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 29
- 235000013399 edible fruits Nutrition 0.000 claims description 29
- 229940114496 olive leaf extract Drugs 0.000 claims description 29
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 28
- 235000019136 lipoic acid Nutrition 0.000 claims description 27
- 229960002663 thioctic acid Drugs 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 230000002503 metabolic effect Effects 0.000 claims description 19
- 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 claims description 18
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 18
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 16
- 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 claims description 15
- 239000000729 antidote Substances 0.000 claims description 12
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 9
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 9
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 9
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 9
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 235000005805 Prunus cerasus Nutrition 0.000 claims description 9
- 244000207449 Prunus puddum Species 0.000 claims description 9
- 235000009226 Prunus puddum Nutrition 0.000 claims description 9
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 9
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 9
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 9
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 9
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 9
- 235000012754 curcumin Nutrition 0.000 claims description 9
- 239000004148 curcumin Substances 0.000 claims description 9
- 229940109262 curcumin Drugs 0.000 claims description 9
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 9
- 230000002708 enhancing effect Effects 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 229940038487 grape extract Drugs 0.000 claims description 9
- 235000012680 lutein Nutrition 0.000 claims description 9
- 239000001656 lutein Substances 0.000 claims description 9
- 229960005375 lutein Drugs 0.000 claims description 9
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 9
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 9
- 235000012661 lycopene Nutrition 0.000 claims description 9
- 239000001751 lycopene Substances 0.000 claims description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 9
- 229960004999 lycopene Drugs 0.000 claims description 9
- 229940109529 pomegranate extract Drugs 0.000 claims description 9
- 230000001737 promoting effect Effects 0.000 claims description 9
- 235000021283 resveratrol Nutrition 0.000 claims description 9
- 229940016667 resveratrol Drugs 0.000 claims description 9
- 235000020748 rosemary extract Nutrition 0.000 claims description 9
- 229940092258 rosemary extract Drugs 0.000 claims description 9
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 9
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 9
- 235000010930 zeaxanthin Nutrition 0.000 claims description 9
- 239000001775 zeaxanthin Substances 0.000 claims description 9
- 229940043269 zeaxanthin Drugs 0.000 claims description 9
- -1 elixirs Substances 0.000 claims description 8
- 238000001784 detoxification Methods 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000020708 ginger extract Nutrition 0.000 claims description 4
- 229940002508 ginger extract Drugs 0.000 claims description 4
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims description 3
- 101001071611 Dictyostelium discoideum Glutathione reductase Proteins 0.000 claims description 3
- 102100039696 Glutamate-cysteine ligase catalytic subunit Human genes 0.000 claims description 3
- 102100033398 Glutamate-cysteine ligase regulatory subunit Human genes 0.000 claims description 3
- 102100037473 Glutathione S-transferase A1 Human genes 0.000 claims description 3
- 102100033039 Glutathione peroxidase 1 Human genes 0.000 claims description 3
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 claims description 3
- 102100028006 Heme oxygenase 1 Human genes 0.000 claims description 3
- 101001034527 Homo sapiens Glutamate-cysteine ligase catalytic subunit Proteins 0.000 claims description 3
- 101000870644 Homo sapiens Glutamate-cysteine ligase regulatory subunit Proteins 0.000 claims description 3
- 101001026125 Homo sapiens Glutathione S-transferase A1 Proteins 0.000 claims description 3
- 101001014936 Homo sapiens Glutathione peroxidase 1 Proteins 0.000 claims description 3
- 101001071608 Homo sapiens Glutathione reductase, mitochondrial Proteins 0.000 claims description 3
- 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 claims description 3
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 claims description 3
- 101001128158 Homo sapiens Nanos homolog 2 Proteins 0.000 claims description 3
- 101001128156 Homo sapiens Nanos homolog 3 Proteins 0.000 claims description 3
- 101001124309 Homo sapiens Nitric oxide synthase, endothelial Proteins 0.000 claims description 3
- 101001124991 Homo sapiens Nitric oxide synthase, inducible Proteins 0.000 claims description 3
- 101000829725 Homo sapiens Phospholipid hydroperoxide glutathione peroxidase Proteins 0.000 claims description 3
- 101000644537 Homo sapiens Sequestosome-1 Proteins 0.000 claims description 3
- 101000704557 Homo sapiens Sulfiredoxin-1 Proteins 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 claims description 3
- 108010071382 NF-E2-Related Factor 2 Proteins 0.000 claims description 3
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 claims description 3
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 claims description 3
- 102100023410 Phospholipid hydroperoxide glutathione peroxidase Human genes 0.000 claims description 3
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims description 3
- 102100020814 Sequestosome-1 Human genes 0.000 claims description 3
- 102100031797 Sulfiredoxin-1 Human genes 0.000 claims description 3
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 claims description 3
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 claims description 3
- 102100040198 UDP-glucuronosyltransferase 1-6 Human genes 0.000 claims description 3
- 101710008381 UGT1A6 Proteins 0.000 claims description 3
- 230000004900 autophagic degradation Effects 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 239000007937 lozenge Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000012431 wafers Nutrition 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 description 33
- 230000037396 body weight Effects 0.000 description 2
- 244000308180 Brassica oleracea var. italica Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020687 goji berry extract Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161452478P | 2011-03-14 | 2011-03-14 | |
| US61/452,478 | 2011-03-14 | ||
| PCT/US2012/029136 WO2012125772A2 (en) | 2011-03-14 | 2012-03-14 | Oral formulations for promoting cellular purification |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018035032A Division JP2018087246A (ja) | 2011-03-14 | 2018-02-28 | 細胞浄化を促進するための経口製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014510081A JP2014510081A (ja) | 2014-04-24 |
| JP2014510081A5 true JP2014510081A5 (enExample) | 2015-04-30 |
| JP6625792B2 JP6625792B2 (ja) | 2019-12-25 |
Family
ID=46831336
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558154A Active JP6625792B2 (ja) | 2011-03-14 | 2012-03-14 | 細胞浄化を促進するための経口製剤 |
| JP2018035032A Withdrawn JP2018087246A (ja) | 2011-03-14 | 2018-02-28 | 細胞浄化を促進するための経口製剤 |
| JP2019121344A Pending JP2019154453A (ja) | 2011-03-14 | 2019-06-28 | 細胞浄化を促進するための経口製剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018035032A Withdrawn JP2018087246A (ja) | 2011-03-14 | 2018-02-28 | 細胞浄化を促進するための経口製剤 |
| JP2019121344A Pending JP2019154453A (ja) | 2011-03-14 | 2019-06-28 | 細胞浄化を促進するための経口製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20130071369A1 (enExample) |
| EP (1) | EP2686021B1 (enExample) |
| JP (3) | JP6625792B2 (enExample) |
| KR (1) | KR102090836B1 (enExample) |
| CN (1) | CN103732258A (enExample) |
| SG (2) | SG10201703576WA (enExample) |
| WO (1) | WO2012125772A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120143228A1 (en) | 2010-08-30 | 2012-06-07 | Agency For Science Technology And Research | Adhesive structure with stiff protrusions on adhesive surface |
| US9492952B2 (en) | 2010-08-30 | 2016-11-15 | Endo-Surgery, Inc. | Super-hydrophilic structures |
| WO2013102085A1 (en) | 2011-12-29 | 2013-07-04 | Ethicon, Inc. | Adhesive structure with tissue piercing protrusions on its surface |
| US8969648B2 (en) | 2012-04-06 | 2015-03-03 | Ethicon, Inc. | Blood clotting substrate and medical device |
| US8926881B2 (en) | 2012-04-06 | 2015-01-06 | DePuy Synthes Products, LLC | Super-hydrophobic hierarchical structures, method of forming them and medical devices incorporating them |
| JP6825809B2 (ja) | 2012-11-26 | 2021-02-10 | アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー | 抗酸化栄養補助食品と、それに関連する方法 |
| WO2015030293A1 (ko) * | 2013-08-30 | 2015-03-05 | 씨제이제일제당 (주) | 포도 및 오미자 복합 추출물을 포함하는 대사증후군 관련 질환의 예방 또는 치료용 조성물 |
| EP3075384B1 (en) | 2013-09-30 | 2018-11-21 | Sunstar Inc. | Anti-obesity composition |
| WO2016037971A1 (en) | 2014-09-08 | 2016-03-17 | Bios Line S.P.A. | Compositions comprising glucosinolates precursors of sulforaphane in combination with extracts of rosemary |
| CN104382983A (zh) * | 2014-11-28 | 2015-03-04 | 哈尔滨墨医生物技术有限公司 | 一种藏虫草提取物软胶囊及其制备方法 |
| FR3046935B1 (fr) * | 2016-01-21 | 2020-12-25 | Ly Eang Hay | Composition a visee detoxifiante pour administration par voie orale et son procede de preparation |
| JP2016121178A (ja) * | 2016-03-03 | 2016-07-07 | サンスター株式会社 | 抗酸化機能亢進剤 |
| CN111499615B (zh) | 2017-08-04 | 2024-02-02 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| CN114007613A (zh) | 2019-02-05 | 2022-02-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| US11541094B2 (en) | 2019-08-06 | 2023-01-03 | Healthrite Partners, LLC | Formulations for treating metabolic syndrome and increasing energy levels |
| US20210213095A1 (en) * | 2020-01-13 | 2021-07-15 | Lifevantage Corporation | Compositions and methods for activating cellular signaling pathways |
| AU2021347101A1 (en) | 2020-09-24 | 2023-04-13 | Mars, Incorporated | Food compositions and applications thereof |
| US11541116B1 (en) | 2022-01-07 | 2023-01-03 | Kojin Therapeutics, Inc. | Methods and compositions for inducing ferroptosis in vivo |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2346325A (en) * | 1999-02-02 | 2000-08-09 | Wassen Int Ltd | Formulation comprising a brassica extract or sulforaphane and resveratrol |
| US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| JPWO2006043671A1 (ja) * | 2004-10-22 | 2008-05-22 | キリンホールディングス株式会社 | 転写因子Ｎｒｆ２活性化剤およびその機能が付与された食品 |
| EP1937288A4 (en) * | 2005-10-11 | 2012-04-04 | Lycored Ltd | CAROTENOID OXIDATION PRODUCTS AS CHEMOPRVENTIVE AND CHEMOTHERAPEUTIC MTITEL |
| US8017147B2 (en) * | 2008-04-07 | 2011-09-13 | Mazed Mohammad A | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| US20080305096A1 (en) * | 2007-06-07 | 2008-12-11 | Unicity International, Inc. | Method and composition for providing controlled delivery of biologically active substances |
| WO2009036204A2 (en) * | 2007-09-11 | 2009-03-19 | Joslin Diabetes Center, Inc. | Phase ii detoxification and antioxidant activity |
| EP2418965B1 (en) * | 2009-04-17 | 2016-06-29 | DSM IP Assets B.V. | Hydroxytyrosol combinations for enhancing mitochondrial function and energy production. |
| US9072780B2 (en) * | 2010-05-24 | 2015-07-07 | Nse Products, Inc. | Oral formulations for counteracting effects of aging |
-
2012
- 2012-03-14 KR KR1020137026684A patent/KR102090836B1/ko active Active
- 2012-03-14 JP JP2013558154A patent/JP6625792B2/ja active Active
- 2012-03-14 SG SG10201703576WA patent/SG10201703576WA/en unknown
- 2012-03-14 CN CN201280023826.9A patent/CN103732258A/zh active Pending
- 2012-03-14 SG SG2013067640A patent/SG193370A1/en unknown
- 2012-03-14 EP EP12758097.5A patent/EP2686021B1/en active Active
- 2012-03-14 US US13/420,547 patent/US20130071369A1/en not_active Abandoned
- 2012-03-14 WO PCT/US2012/029136 patent/WO2012125772A2/en not_active Ceased
-
2017
- 2017-08-13 US US15/675,761 patent/US20180078601A1/en not_active Abandoned
-
2018
- 2018-02-28 JP JP2018035032A patent/JP2018087246A/ja not_active Withdrawn
-
2019
- 2019-06-28 JP JP2019121344A patent/JP2019154453A/ja active Pending
-
2021
- 2021-03-29 US US17/216,443 patent/US20210290721A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014510081A5 (enExample) | ||
| JP2018087246A5 (enExample) | ||
| EP2686021B1 (en) | Oral formulations for promoting cellular purification | |
| RU2479313C2 (ru) | Способ лечения или профилактики заболеваний дыхательных путей, включающий введение холекальциферола | |
| JP2008542300A (ja) | 炎症と関連した状態を予防及び治療するための組成物及び方法 | |
| JP2009537466A (ja) | ジンセノサイド類およびそれらを含有する抽出物の使用 | |
| US20180042862A1 (en) | Antioxidant dietary supplement compositions and methods for maintaining healthy skin | |
| JP2018530517A (ja) | 一酸化窒素レベルを急激に上昇させるための組成物および方法 | |
| JP2012236834A5 (enExample) | ||
| JP2013526611A5 (enExample) | ||
| NL2033616B1 (en) | Anti-ageing supplement | |
| CA2839972C (en) | Compositions containing broccoli seeds extract for treating or preventing prostate cancer | |
| ES2673010T3 (es) | Composición que tiene un efecto beneficioso sobre el sistema cardiovascular, que comprende monacolina k, licopeno y vitamina D3 | |
| WO2021240293A1 (en) | Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system | |
| DE202011105533U1 (de) | Vitalstoff-Zusammensetzung gemäß asiatischer und mediterraner Ernährungskonzepte | |
| TWI411440B (zh) | 桂花萃取物在製備預防或治療憂鬱症藥物或保健食品之用途 | |
| Gencoglu et al. | Phytochemical therapies in vascular functioning: a molecular approach | |
| EP3046568A1 (en) | Dietary supplements for treating adhd and related disorders | |
| ES2986705T3 (es) | Extracto de aceituna adecuado para reducir el índice de masa corporal y la grasa visceral en sujetos con sobrepeso | |
| RU2014146562A (ru) | Композиция, содержащая альфа-липоевую кислоту и гонокиол, для лечения нейропатий | |
| ES2971121T3 (es) | Métodos para mejorar el rendimiento físico y composiciones de guindilla utilizadas para ello | |
| US20070224215A1 (en) | Brown seaweed extracts in capsules consisting of broad-spectrum freeze dried antioxidant concentrates, Fucoidan, crystalloidals, Mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin C, and black pepper extract with delivery systems for utilization of nutrients | |
| US20200108039A1 (en) | Compositions of medium chaintryglycerides (MCT) and plant-based nutrients for brain health | |
| Bharti et al. | Overview Of Covid-19: Its Prevention And Management In The Light Of Some Nutraceuticals (A Review) | |
| IT202000026566A1 (it) | Combinazioni di antivirali e antimicrobici naturali, loro uso e formulazioni che le contengono |